Immune reconstitution after autologous hematopoietic stem cell transplantation. 2001

L F Porrata, and M R Litzow, and S N Markovic
Department of Oncology, Mayo Cinic, Rochester, Minn. 55905, USA.

Autologous hematopoietic stem cell transplantation has proved to be an effective treatment for certain hematologic malignancies. However, relapse rates are high during the first year after transplantation. These relapses are attributed to the failure of high-dose chemotherapy to eradicate minimal residual malignant disease. In allogeneic hematopoietic stem cell transplantation, the higher antitumor effects observed compared with those in autologous hematopoietic stem cell transplantation are based on the immunologically mediated graft-vs-tumor effect. Therefore, a better understanding of the mechanisms involved in immune reconstitution after hematopoietic stem cell transplantation may clarify the importance of various components of the recovery of the immune system as they pertain to eradication of residual tumor, as well as uncover possible interventions directed at maximizing this effect. This review focuses on immune reconstitution after autologous hematopoietic stem cell transplantation. Autologous hematopoietic stem cell transplantation is not affected by graft-vs-host disease or immunosuppressive therapy after transplantation to control graft-vs-host disease, providing a direct insight into the mechanisms involved in immune reconstitution after engraftment.

UI MeSH Term Description Entries
D007121 Immunocompetence The ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen. Competence, Immunologic,Immunologic Competence,Immunological Competence,Competence, Immunological
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014181 Transplantation Immunology A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection. Immunology, Transplantation
D014182 Transplantation, Autologous Transplantation of an individual's own tissue from one site to another site. Autografting,Autologous Transplantation,Autotransplantation,Autograftings,Autologous Transplantations,Autotransplantations,Transplantations, Autologous
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses

Related Publications

L F Porrata, and M R Litzow, and S N Markovic
September 1998, Blood,
L F Porrata, and M R Litzow, and S N Markovic
February 2014, Clinical & translational immunology,
L F Porrata, and M R Litzow, and S N Markovic
April 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
L F Porrata, and M R Litzow, and S N Markovic
June 2016, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences,
L F Porrata, and M R Litzow, and S N Markovic
January 2016, Frontiers in immunology,
L F Porrata, and M R Litzow, and S N Markovic
August 2006, Ai zheng = Aizheng = Chinese journal of cancer,
L F Porrata, and M R Litzow, and S N Markovic
November 2022, Neurology(R) neuroimmunology & neuroinflammation,
L F Porrata, and M R Litzow, and S N Markovic
June 2007, Best practice & research. Clinical haematology,
L F Porrata, and M R Litzow, and S N Markovic
January 2001, Cytotherapy,
L F Porrata, and M R Litzow, and S N Markovic
July 2012, Current opinion in hematology,
Copied contents to your clipboard!